Popular New
- Checkpoint protein expression in the tumor microenvironment defines the outcome of classical Hodgkin lymphoma patients56 daysLeppä, S(irpa)*Read
- Molecular features encoded in the ctDNA reveal heterogeneity and predict outcome in high-risk aggressive B-cell lymphoma56 daysLeppä, S(irpa)*Read
- Transformation and outcome of nodular lymphocyte predominant Hodgkin lymphoma: a Finnish Nationwide population-based study56 daysLeppä, S(irpa)*Read
- Clinical Impact of Immune Cells and Their Spatial Interactions in Diffuse Large B-Cell Lymphoma Microenvironment56 daysLeppä, S(irpa)*Read
- Testicular Diffuse Large B-Cell Lymphoma-Clinical, Molecular, and Immunological Features56 daysLeppä, S(irpa)*Read
- Feasibility of Combining the Phosphatidylinositol 3-Kinase Inhibitor Copanlisib With Rituximab-Based Immunochemotherapy in Patients With Relapsed Indolent B-cell Lymphoma56 daysLeppä, S(irpa)*Read
- Treatment response of colorectal cancer liver metastases to neoadjuvant or conversion therapy: a prospective multicentre follow-up study using MRI, diffusion-weighted imaging and <sup>1</sup>H-MR spectroscopy compared with histology (subg56 daysLeppä, S(irpa)*Read
- Prognostic impact of soluble CD163 in patients with diffuse large B-cell lymphoma56 daysLeppä, S(irpa)*Read
- Soluble PD-1 but Not PD-L1 Levels Predict Poor Outcome in Patients with High-Risk Diffuse Large B-Cell Lymphoma56 daysLeppä, S(irpa)*Read
- Immunogenomic Landscape of Hematological Malignancies56 daysLeppä, S(irpa)*Read
- Molecular background delineates outcome of double protein expressor diffuse large B-cell lymphoma56 daysLeppä, S(irpa)*Read
- Low Absolute Lymphocyte Counts in the Peripheral Blood Predict Inferior Survival and Improve the International Prognostic Index in Testicular Diffuse Large B-Cell Lymphoma56 daysLeppä, S(irpa)*Read
- Immunogenomic Landscape of Hematological Malignancies56 daysLeppä, S(irpa)*Read
- Adverse prognostic impact of regulatory T-cells in testicular diffuse large B-cell lymphoma56 daysLeppä, S(irpa)*Read
- Patients with high-risk DLBCL benefit from dose-dense immunochemotherapy combined with early systemic CNS prophylaxis56 daysLeppä, S(irpa)*Read
- Mutational dynamics and immune evasion in diffuse large B-cell lymphoma explored in a relapse-enriched patient series56 daysLeppä, S(irpa)*Read
- Prognostic Impact of Tumor-Associated Macrophages on Survival Is Checkpoint Dependent in Classical Hodgkin Lymphoma56 daysLeppä, S(irpa)*Read
- <em>STAT3</em> Mutation Is Associated with STAT3 Activation in CD30<sup>+</sup> ALK<sup>-</sup> ALCL56 daysLeppä, S(irpa)*Read
- Immune cell constitution in the tumor microenvironment predicts the outcome in diffuse large B-cell lymphoma56 daysLeppä, S(irpa)*Read
- Long-term safety and efficacy of the PI3K inhibitor copanlisib in patients with relapsed or refractory indolent lymphoma: 2-year follow-up of the CHRONOS-1 study56 daysLeppä, S(irpa)*Read
- Drug screening approach combines epigenetic sensitization with immunochemotherapy in cancer56 daysLeppä, S(irpa)*Read
- Sustained Progression-Free Survival Benefit of Rituximab Maintenance in Patients With Follicular Lymphoma: Long-Term Results of the PRIMA Study56 daysLeppä, S(irpa)*Read
- Pixantrone beyond monotherapy: a review56 daysLeppä, S(irpa)*Read
- Distinct subtypes of diffuse large B-cell lymphoma defined by hypermutated genes56 daysLeppä, S(irpa)*Read
- Intravenous but not intrathecal central nervous system-directed chemotherapy improves survival in patients with testicular diffuse large B-cell lymphoma56 daysLeppä, S(irpa)*Read
- Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell Lymphoma56 daysLeppä, S(irpa)*Read
- Clinical features and outcome of the patients with sinonasal tract diffuse large B-cell lymphoma in the pre-rituximab and rituximab eras56 daysLeppä, S(irpa)*Read
- Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial56 daysLeppä, S(irpa)*Read
- T-cell inflamed tumor microenvironment predicts favorable prognosis in primary testicular lymphoma56 daysLeppä, S(irpa)*Read
- PD-L1<sup>+</sup> tumor-associated macrophages and PD-1<sup>+</sup> tumor-infiltrating lymphocytes predict survival in primary testicular lymphoma56 daysLeppä, S(irpa)*Read
- Up-front rituximab maintenance improves outcome in patients with follicular lymphoma: a collaborative Nordic study56 daysLeppä, S(irpa)*Read
- Identifying differentially methylated sites in samples with varying tumor purity56 daysLeppä, S(irpa)*Read
- MicroRNAs regulate key cell survival pathways and mediate chemosensitivity during progression of diffuse large B-cell lymphoma56 daysLeppä, S(irpa)*Read
- Clinical significance of gene defects in B-cell lymphomas56 daysLeppä, S(irpa)*Read
- HIV infection and cancer56 daysLeppä, S(irpa)*Read
- Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma56 daysLeppä, S(irpa)*Read
- Phosphatidylinositol 3-Kinase Inhibition by Copanlisib in Relapsed or Refractory Indolent Lymphoma56 daysLeppä, S(irpa)*Read
- Alternative splicing discriminates molecular subtypes and has prognostic impact in diffuse large B-cell lymphoma56 daysLeppä, S(irpa)*Read
- Clinical findings in 25 patients with sinonasal or nasopharyngeal extramedullary plasmacytoma in a four-decade single-centre series56 daysLeppä, S(irpa)*Read
- Enteropathy-associated T cell lymphoma subtypes are characterized by loss of function of SETD256 daysLeppä, S(irpa)*Read
- Deltex-1 mutations predict poor survival in diffuse large B-cell lymphoma56 daysLeppä, S(irpa)*Read
- Ofatumumab Versus Rituximab Salvage Chemoimmunotherapy in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: The ORCHARRD Study56 daysLeppä, S(irpa)*Read
- Plasma immunoprofiling of patients with high-risk diffuse large B-cell lymphoma: a Nordic Lymphoma Group study56 daysLeppä, S(irpa)*Read
- FGF21 is a biomarker for mitochondrial translation and mtDNA maintenance disorders56 daysLeppä, S(irpa)*Read
- Risk Factors and Outcomes for Patients With Follicular Lymphoma Who Had Histologic Transformation After Response to First-Line Immunochemotherapy in the PRIMA Trial56 daysLeppä, S(irpa)*Read
- Randomized, Double-Blind, Phase III Trial of Enzastaurin Versus Placebo in Patients Achieving Remission After First-Line Therapy for High-Risk Diffuse Large B-Cell Lymphoma56 daysLeppä, S(irpa)*Read
- Clinical findings of extranodal SNT lymphoid malignancies in a four-decade single-centre series56 daysLeppä, S(irpa)*Read
- Total peroxiredoxin expression is associated with survival in patients with follicular lymphoma56 daysLeppä, S(irpa)*Read
- Allogeneic Haematopoietic Stem Cell Transplantation for Patients with Cutaneous T-cell Lymphoma56 daysLeppä, S(irpa)*Read
- Constant pattern of relapse in primary central nervous lymphoma patients treated with high-dose methotrexate combinations. A Finnish retrospective study56 daysLeppä, S(irpa)*Read

Impact Factor: 9.314
SJR: 4.719
JUFO: 1.48
Articles: 50
Terkko Factor: 403.3 (√IF*SJR*JUFO * Num)
Based on articles published in the last 12 months.
Profile on PlumX
- Medicine - All Feeds
- Allergology and Immunology
- Anatomy and Physiology
- Anesthesiology and Intensive Care
- Biochemistry
- Bioengineering
- Biophysics
- Biotechnology
- Cardiology
- Cardiothoracic Surgery
- Clinical Chemistry
- Clinical Medicine
- Complementary Medicine
- Cytology and Histology
- Dentistry
- Dermatology
- Endocrinology
- Forensic Medicine
- Gastroenterology
- General Practice
- Genetics
- Geriatrics
- Health services and Administration
- Hematology
- Infectious Diseases
- Internal Medicine
- Logopedics
- Medical Education and Humanities
- Medical Microbiology
- Medicine - Other
- Nephrology
- Neurology
- Neurosurgery
- Nursing
- Nutritional Sciences
- Obstetrics and Gynecology
- Occupational Health
- Oncology
- Ophthalmology
- Oral and Maxillofacial Surgery
- Orthopedics and Traumatology
- Otorhinolaryngology and Phoniatrics
- Pathology
- Pediatrics
- Pharmacology and Pharmacotherapy
- Physical and Rehabilitation Medicine
- Plastic Surgery
- Psychiatry
- Psychology
- Public Health
- Radiology
- Respiratory Medicine
- Rheumatology
- Sports Medicine
- Surgery
- Urology